The company expects the final trial visits and the collection of data to take place by the second quarter of this year.

The Independent Data Monitoring Committee (IDMC) has recommended the study continue without modifications, citing no safety concerns from the data reviewed. According to InvestingPro data ...

Independent Data Monitoring Committee (the “DMC”) recommends continuation of sunRIZE trial as planned with no need to increase sample size ...